Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection
Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-dose, two-period study that will consist of a combined screening
and baseline period and an open-label treatment period. Subjects will be enrolled when they
experience an Upper Respiratory Tract Infection with nasal congestion and edema.